nodes	percent_of_prediction	percent_of_DWPC	metapath
Asenapine—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.252	1	CbGbCtD
Asenapine—Hypoaesthesia oral—Riluzole—amyotrophic lateral sclerosis	0.0303	0.0796	CcSEcCtD
Asenapine—HTR2A—phrenic nerve—amyotrophic lateral sclerosis	0.0214	0.0757	CbGeAlD
Asenapine—Traumatic liver injury—Riluzole—amyotrophic lateral sclerosis	0.0212	0.0557	CcSEcCtD
Asenapine—Paraesthesia oral—Riluzole—amyotrophic lateral sclerosis	0.0169	0.0443	CcSEcCtD
Asenapine—Bundle branch block—Riluzole—amyotrophic lateral sclerosis	0.0157	0.0411	CcSEcCtD
Asenapine—Completed suicide—Riluzole—amyotrophic lateral sclerosis	0.0134	0.0353	CcSEcCtD
Asenapine—Upset stomach—Riluzole—amyotrophic lateral sclerosis	0.0121	0.0317	CcSEcCtD
Asenapine—HTR1B—cranial nerve—amyotrophic lateral sclerosis	0.0116	0.041	CbGeAlD
Asenapine—HTR1D—cranial nerve—amyotrophic lateral sclerosis	0.0112	0.0397	CbGeAlD
Asenapine—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0276	CcSEcCtD
Asenapine—Liver injury—Riluzole—amyotrophic lateral sclerosis	0.0094	0.0247	CcSEcCtD
Asenapine—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.009	0.0236	CcSEcCtD
Asenapine—HTR7—cranial nerve—amyotrophic lateral sclerosis	0.00894	0.0316	CbGeAlD
Asenapine—HTR7—pons—amyotrophic lateral sclerosis	0.00883	0.0313	CbGeAlD
Asenapine—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.00836	0.022	CcSEcCtD
Asenapine—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.00836	0.022	CcSEcCtD
Asenapine—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00791	0.0208	CcSEcCtD
Asenapine—DRD1—nerve—amyotrophic lateral sclerosis	0.00733	0.0259	CbGeAlD
Asenapine—HTR5A—nervous system—amyotrophic lateral sclerosis	0.00662	0.0234	CbGeAlD
Asenapine—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.0066	0.0173	CcSEcCtD
Asenapine—HTR5A—central nervous system—amyotrophic lateral sclerosis	0.00637	0.0226	CbGeAlD
Asenapine—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00611	0.016	CcSEcCtD
Asenapine—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00593	0.0156	CcSEcCtD
Asenapine—HTR7—peripheral nervous system—amyotrophic lateral sclerosis	0.00587	0.0208	CbGeAlD
Asenapine—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.00576	0.0151	CcSEcCtD
Asenapine—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00574	0.0151	CcSEcCtD
Asenapine—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00561	0.0147	CcSEcCtD
Asenapine—HTR2A—cranial nerve—amyotrophic lateral sclerosis	0.00557	0.0197	CbGeAlD
Asenapine—HTR2A—pons—amyotrophic lateral sclerosis	0.00551	0.0195	CbGeAlD
Asenapine—HTR1E—brainstem—amyotrophic lateral sclerosis	0.00539	0.0191	CbGeAlD
Asenapine—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00524	0.0138	CcSEcCtD
Asenapine—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00519	0.0136	CcSEcCtD
Asenapine—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00506	0.0133	CcSEcCtD
Asenapine—HTR5A—brain—amyotrophic lateral sclerosis	0.00506	0.0179	CbGeAlD
Asenapine—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00496	0.013	CcSEcCtD
Asenapine—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00476	0.0125	CcSEcCtD
Asenapine—HTR2A—hindlimb—amyotrophic lateral sclerosis	0.0047	0.0166	CbGeAlD
Asenapine—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00464	0.0122	CcSEcCtD
Asenapine—HTR7—nerve—amyotrophic lateral sclerosis	0.00458	0.0162	CbGeAlD
Asenapine—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00452	0.0119	CcSEcCtD
Asenapine—Depression—Riluzole—amyotrophic lateral sclerosis	0.00441	0.0116	CcSEcCtD
Asenapine—DRD2—nerve—amyotrophic lateral sclerosis	0.00433	0.0153	CbGeAlD
Asenapine—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00431	0.0113	CcSEcCtD
Asenapine—ADRA2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00431	0.0153	CbGeAlD
Asenapine—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00418	0.011	CcSEcCtD
Asenapine—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00413	0.0108	CcSEcCtD
Asenapine—SLC6A4—hindbrain—amyotrophic lateral sclerosis	0.00404	0.0143	CbGeAlD
Asenapine—HTR2A—appendage—amyotrophic lateral sclerosis	0.00403	0.0143	CbGeAlD
Asenapine—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00391	0.0103	CcSEcCtD
Asenapine—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.0039	0.0102	CcSEcCtD
Asenapine—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00371	0.00974	CcSEcCtD
Asenapine—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00369	0.00968	CcSEcCtD
Asenapine—HTR2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00366	0.013	CbGeAlD
Asenapine—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.0036	0.00946	CcSEcCtD
Asenapine—HTR1A—hindbrain—amyotrophic lateral sclerosis	0.00359	0.0127	CbGeAlD
Asenapine—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00359	0.00942	CcSEcCtD
Asenapine—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00358	0.0094	CcSEcCtD
Asenapine—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00348	0.00914	CcSEcCtD
Asenapine—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00346	0.00908	CcSEcCtD
Asenapine—HTR7—hindbrain—amyotrophic lateral sclerosis	0.00343	0.0121	CbGeAlD
Asenapine—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00339	0.00889	CcSEcCtD
Asenapine—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00332	0.00873	CcSEcCtD
Asenapine—ADRA1A—hindbrain—amyotrophic lateral sclerosis	0.00331	0.0117	CbGeAlD
Asenapine—DRD2—hindbrain—amyotrophic lateral sclerosis	0.00324	0.0115	CbGeAlD
Asenapine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00324	0.0085	CcSEcCtD
Asenapine—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.0032	0.00839	CcSEcCtD
Asenapine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00318	0.00834	CcSEcCtD
Asenapine—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00316	0.00829	CcSEcCtD
Asenapine—DRD1—brainstem—amyotrophic lateral sclerosis	0.00315	0.0111	CbGeAlD
Asenapine—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00312	0.00819	CcSEcCtD
Asenapine—Syncope—Riluzole—amyotrophic lateral sclerosis	0.0031	0.00814	CcSEcCtD
Asenapine—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00309	0.00813	CcSEcCtD
Asenapine—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00304	0.00798	CcSEcCtD
Asenapine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.003	0.00786	CcSEcCtD
Asenapine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00298	0.00784	CcSEcCtD
Asenapine—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00294	0.00773	CcSEcCtD
Asenapine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00293	0.0077	CcSEcCtD
Asenapine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00288	0.00756	CcSEcCtD
Asenapine—HTR2A—nerve—amyotrophic lateral sclerosis	0.00286	0.0101	CbGeAlD
Asenapine—HTR1E—nervous system—amyotrophic lateral sclerosis	0.00282	0.01	CbGeAlD
Asenapine—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00282	0.00741	CcSEcCtD
Asenapine—Shock—Riluzole—amyotrophic lateral sclerosis	0.00278	0.00729	CcSEcCtD
Asenapine—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00277	0.00727	CcSEcCtD
Asenapine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00276	0.00725	CcSEcCtD
Asenapine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00275	0.00723	CcSEcCtD
Asenapine—HTR1E—central nervous system—amyotrophic lateral sclerosis	0.00272	0.00963	CbGeAlD
Asenapine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00264	0.00692	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00257	0.00675	CcSEcCtD
Asenapine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00255	0.0067	CcSEcCtD
Asenapine—HTR1B—brainstem—amyotrophic lateral sclerosis	0.00255	0.00903	CbGeAlD
Asenapine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00252	0.0066	CcSEcCtD
Asenapine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00251	0.00659	CcSEcCtD
Asenapine—DRD4—brain—amyotrophic lateral sclerosis	0.0025	0.00886	CbGeAlD
Asenapine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00248	0.00652	CcSEcCtD
Asenapine—HTR1D—brainstem—amyotrophic lateral sclerosis	0.00247	0.00874	CbGeAlD
Asenapine—HTR2C—brainstem—amyotrophic lateral sclerosis	0.00244	0.00865	CbGeAlD
Asenapine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00244	0.0064	CcSEcCtD
Asenapine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00243	0.00639	CcSEcCtD
Asenapine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00241	0.00634	CcSEcCtD
Asenapine—SLC6A4—brainstem—amyotrophic lateral sclerosis	0.00232	0.0082	CbGeAlD
Asenapine—DRD3—nervous system—amyotrophic lateral sclerosis	0.0023	0.00815	CbGeAlD
Asenapine—DRD3—central nervous system—amyotrophic lateral sclerosis	0.00222	0.00785	CbGeAlD
Asenapine—HTR6—nervous system—amyotrophic lateral sclerosis	0.00222	0.00785	CbGeAlD
Asenapine—HTR1E—brain—amyotrophic lateral sclerosis	0.00216	0.00764	CbGeAlD
Asenapine—HTR2A—hindbrain—amyotrophic lateral sclerosis	0.00214	0.00757	CbGeAlD
Asenapine—HTR6—central nervous system—amyotrophic lateral sclerosis	0.00213	0.00755	CbGeAlD
Asenapine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00208	0.00546	CcSEcCtD
Asenapine—HTR1A—brainstem—amyotrophic lateral sclerosis	0.00206	0.00728	CbGeAlD
Asenapine—HRH2—nervous system—amyotrophic lateral sclerosis	0.00203	0.00717	CbGeAlD
Asenapine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00202	0.00532	CcSEcCtD
Asenapine—HTR7—brainstem—amyotrophic lateral sclerosis	0.00197	0.00696	CbGeAlD
Asenapine—HRH2—central nervous system—amyotrophic lateral sclerosis	0.00195	0.00691	CbGeAlD
Asenapine—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00195	0.0069	CbGeAlD
Asenapine—ADRA1A—brainstem—amyotrophic lateral sclerosis	0.0019	0.00671	CbGeAlD
Asenapine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00187	0.0049	CcSEcCtD
Asenapine—DRD2—brainstem—amyotrophic lateral sclerosis	0.00186	0.00658	CbGeAlD
Asenapine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00471	CcSEcCtD
Asenapine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00467	CcSEcCtD
Asenapine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00467	CcSEcCtD
Asenapine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00464	CcSEcCtD
Asenapine—DRD3—brain—amyotrophic lateral sclerosis	0.00176	0.00623	CbGeAlD
Asenapine—HTR2C—medulla oblongata—amyotrophic lateral sclerosis	0.0017	0.00603	CbGeAlD
Asenapine—HTR6—brain—amyotrophic lateral sclerosis	0.00169	0.006	CbGeAlD
Asenapine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00168	0.0044	CcSEcCtD
Asenapine—DRD1—nervous system—amyotrophic lateral sclerosis	0.00165	0.00584	CbGeAlD
Asenapine—DRD1—central nervous system—amyotrophic lateral sclerosis	0.00159	0.00562	CbGeAlD
Asenapine—HTR1B—spinal cord—amyotrophic lateral sclerosis	0.00159	0.00561	CbGeAlD
Asenapine—HRH2—brain—amyotrophic lateral sclerosis	0.00155	0.00548	CbGeAlD
Asenapine—HTR2C—spinal cord—amyotrophic lateral sclerosis	0.00152	0.00538	CbGeAlD
Asenapine—SLC6A4—spinal cord—amyotrophic lateral sclerosis	0.00144	0.0051	CbGeAlD
Asenapine—HTR7—medulla oblongata—amyotrophic lateral sclerosis	0.00137	0.00485	CbGeAlD
Asenapine—HTR2A—embryo—amyotrophic lateral sclerosis	0.00134	0.00474	CbGeAlD
Asenapine—HTR1B—nervous system—amyotrophic lateral sclerosis	0.00134	0.00473	CbGeAlD
Asenapine—HTR1D—nervous system—amyotrophic lateral sclerosis	0.00129	0.00458	CbGeAlD
Asenapine—HTR1B—central nervous system—amyotrophic lateral sclerosis	0.00129	0.00455	CbGeAlD
Asenapine—HTR2C—nervous system—amyotrophic lateral sclerosis	0.00128	0.00453	CbGeAlD
Asenapine—HTR1A—spinal cord—amyotrophic lateral sclerosis	0.00128	0.00453	CbGeAlD
Asenapine—ADRA2C—medulla oblongata—amyotrophic lateral sclerosis	0.00126	0.00446	CbGeAlD
Asenapine—DRD1—brain—amyotrophic lateral sclerosis	0.00126	0.00446	CbGeAlD
Asenapine—ADRB1—nervous system—amyotrophic lateral sclerosis	0.00126	0.00445	CbGeAlD
Asenapine—HTR1D—central nervous system—amyotrophic lateral sclerosis	0.00124	0.00441	CbGeAlD
Asenapine—HTR2C—central nervous system—amyotrophic lateral sclerosis	0.00123	0.00436	CbGeAlD
Asenapine—HTR2A—brainstem—amyotrophic lateral sclerosis	0.00123	0.00434	CbGeAlD
Asenapine—HTR7—spinal cord—amyotrophic lateral sclerosis	0.00122	0.00433	CbGeAlD
Asenapine—SLC6A4—nervous system—amyotrophic lateral sclerosis	0.00121	0.0043	CbGeAlD
Asenapine—ADRB1—central nervous system—amyotrophic lateral sclerosis	0.00121	0.00428	CbGeAlD
Asenapine—HTR2B—nervous system—amyotrophic lateral sclerosis	0.0012	0.00426	CbGeAlD
Asenapine—SLC6A4—central nervous system—amyotrophic lateral sclerosis	0.00117	0.00414	CbGeAlD
Asenapine—HTR2B—central nervous system—amyotrophic lateral sclerosis	0.00116	0.0041	CbGeAlD
Asenapine—ADRA2C—spinal cord—amyotrophic lateral sclerosis	0.00112	0.00398	CbGeAlD
Asenapine—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00112	0.00395	CbGeAlD
Asenapine—HTR1A—nervous system—amyotrophic lateral sclerosis	0.00108	0.00382	CbGeAlD
Asenapine—HTR1A—central nervous system—amyotrophic lateral sclerosis	0.00104	0.00367	CbGeAlD
Asenapine—HTR7—nervous system—amyotrophic lateral sclerosis	0.00103	0.00365	CbGeAlD
Asenapine—HTR1B—brain—amyotrophic lateral sclerosis	0.00102	0.00361	CbGeAlD
Asenapine—HTR1A—cerebellum—amyotrophic lateral sclerosis	0.00101	0.00359	CbGeAlD
Asenapine—ADRA2A—medulla oblongata—amyotrophic lateral sclerosis	0.00101	0.00356	CbGeAlD
Asenapine—ADRA1A—nervous system—amyotrophic lateral sclerosis	0.000994	0.00352	CbGeAlD
Asenapine—HTR7—central nervous system—amyotrophic lateral sclerosis	0.000992	0.00351	CbGeAlD
Asenapine—HTR1D—brain—amyotrophic lateral sclerosis	0.000988	0.0035	CbGeAlD
Asenapine—HTR2C—brain—amyotrophic lateral sclerosis	0.000979	0.00347	CbGeAlD
Asenapine—DRD2—nervous system—amyotrophic lateral sclerosis	0.000974	0.00345	CbGeAlD
Asenapine—HTR7—cerebellum—amyotrophic lateral sclerosis	0.000969	0.00343	CbGeAlD
Asenapine—ADRB1—brain—amyotrophic lateral sclerosis	0.00096	0.0034	CbGeAlD
Asenapine—ADRA1A—central nervous system—amyotrophic lateral sclerosis	0.000957	0.00339	CbGeAlD
Asenapine—ADRA2C—nervous system—amyotrophic lateral sclerosis	0.000947	0.00335	CbGeAlD
Asenapine—DRD2—central nervous system—amyotrophic lateral sclerosis	0.000938	0.00332	CbGeAlD
Asenapine—ADRA1A—cerebellum—amyotrophic lateral sclerosis	0.000935	0.00331	CbGeAlD
Asenapine—SLC6A4—brain—amyotrophic lateral sclerosis	0.000928	0.00329	CbGeAlD
Asenapine—HTR2B—brain—amyotrophic lateral sclerosis	0.000919	0.00326	CbGeAlD
Asenapine—DRD2—cerebellum—amyotrophic lateral sclerosis	0.000916	0.00324	CbGeAlD
Asenapine—ADRA2C—central nervous system—amyotrophic lateral sclerosis	0.000911	0.00323	CbGeAlD
Asenapine—ADRA2A—spinal cord—amyotrophic lateral sclerosis	0.000897	0.00317	CbGeAlD
Asenapine—ADRA2C—cerebellum—amyotrophic lateral sclerosis	0.000891	0.00315	CbGeAlD
Asenapine—HTR2A—medulla oblongata—amyotrophic lateral sclerosis	0.000855	0.00303	CbGeAlD
Asenapine—HTR1A—brain—amyotrophic lateral sclerosis	0.000824	0.00292	CbGeAlD
Asenapine—HTR7—brain—amyotrophic lateral sclerosis	0.000787	0.00279	CbGeAlD
Asenapine—HRH1—nervous system—amyotrophic lateral sclerosis	0.000769	0.00272	CbGeAlD
Asenapine—HTR2A—spinal cord—amyotrophic lateral sclerosis	0.000762	0.0027	CbGeAlD
Asenapine—ADRA1A—brain—amyotrophic lateral sclerosis	0.000759	0.00269	CbGeAlD
Asenapine—ADRA2A—nervous system—amyotrophic lateral sclerosis	0.000755	0.00267	CbGeAlD
Asenapine—DRD2—brain—amyotrophic lateral sclerosis	0.000744	0.00264	CbGeAlD
Asenapine—HRH1—central nervous system—amyotrophic lateral sclerosis	0.00074	0.00262	CbGeAlD
Asenapine—ADRA2A—central nervous system—amyotrophic lateral sclerosis	0.000727	0.00258	CbGeAlD
Asenapine—ADRA2C—brain—amyotrophic lateral sclerosis	0.000724	0.00256	CbGeAlD
Asenapine—ADRA2A—cerebellum—amyotrophic lateral sclerosis	0.000711	0.00252	CbGeAlD
Asenapine—HTR2A—nervous system—amyotrophic lateral sclerosis	0.000642	0.00227	CbGeAlD
Asenapine—HTR2A—central nervous system—amyotrophic lateral sclerosis	0.000618	0.00219	CbGeAlD
Asenapine—HTR2A—cerebellum—amyotrophic lateral sclerosis	0.000604	0.00214	CbGeAlD
Asenapine—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000595	0.00211	CbGeAlD
Asenapine—HRH1—brain—amyotrophic lateral sclerosis	0.000588	0.00208	CbGeAlD
Asenapine—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000585	0.00207	CbGeAlD
Asenapine—ADRA2A—brain—amyotrophic lateral sclerosis	0.000577	0.00204	CbGeAlD
Asenapine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000573	0.00203	CbGeAlD
Asenapine—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000563	0.00199	CbGeAlD
Asenapine—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000551	0.00195	CbGeAlD
Asenapine—HTR2A—brain—amyotrophic lateral sclerosis	0.000491	0.00174	CbGeAlD
Asenapine—CYP2D6—brain—amyotrophic lateral sclerosis	0.000447	0.00158	CbGeAlD
Asenapine—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	2.6e-05	0.000306	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.6e-05	0.000305	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.58e-05	0.000303	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.56e-05	0.000301	CbGpPWpGaD
Asenapine—ADRA2B—Hemostasis—VEGFA—amyotrophic lateral sclerosis	2.55e-05	0.000299	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.54e-05	0.000298	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.53e-05	0.000298	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.53e-05	0.000298	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.53e-05	0.000297	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.52e-05	0.000297	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.51e-05	0.000296	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.5e-05	0.000294	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	2.5e-05	0.000293	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.46e-05	0.00029	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.46e-05	0.00029	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.46e-05	0.000289	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.45e-05	0.000288	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.44e-05	0.000287	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.43e-05	0.000286	CbGpPWpGaD
Asenapine—ADRA2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	2.43e-05	0.000286	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.42e-05	0.000285	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.42e-05	0.000285	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.42e-05	0.000284	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.41e-05	0.000284	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	2.4e-05	0.000282	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.38e-05	0.00028	CbGpPWpGaD
Asenapine—ADRA2C—Hemostasis—VEGFA—amyotrophic lateral sclerosis	2.38e-05	0.00028	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.37e-05	0.000279	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.37e-05	0.000278	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.36e-05	0.000278	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.33e-05	0.000274	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	2.33e-05	0.000274	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.32e-05	0.000273	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.32e-05	0.000273	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.31e-05	0.000272	CbGpPWpGaD
Asenapine—HTR5A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.31e-05	0.000271	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.29e-05	0.000269	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.29e-05	0.000269	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.26e-05	0.000265	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.25e-05	0.000265	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.25e-05	0.000265	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.25e-05	0.000264	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.24e-05	0.000263	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.24e-05	0.000263	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.22e-05	0.000261	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.21e-05	0.00026	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.21e-05	0.000259	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.19e-05	0.000257	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.18e-05	0.000257	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.18e-05	0.000256	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.17e-05	0.000255	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.15e-05	0.000253	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.15e-05	0.000253	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.14e-05	0.000252	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.11e-05	0.000249	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.11e-05	0.000248	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.09e-05	0.000245	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.08e-05	0.000245	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.08e-05	0.000245	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.07e-05	0.000243	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.07e-05	0.000243	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.07e-05	0.000243	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.05e-05	0.000241	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.05e-05	0.000241	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.04e-05	0.00024	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.04e-05	0.00024	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.03e-05	0.000238	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.01e-05	0.000237	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.01e-05	0.000236	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	2.01e-05	0.000236	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2e-05	0.000235	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.99e-05	0.000234	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.98e-05	0.000233	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.97e-05	0.000232	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.97e-05	0.000232	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.96e-05	0.000231	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.94e-05	0.000228	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.94e-05	0.000228	CbGpPWpGaD
Asenapine—ADRA2A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.93e-05	0.000227	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.93e-05	0.000227	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.93e-05	0.000227	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.92e-05	0.000226	CbGpPWpGaD
Asenapine—ADRA2B—Hemostasis—TP53—amyotrophic lateral sclerosis	1.92e-05	0.000226	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.92e-05	0.000226	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.92e-05	0.000226	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.9e-05	0.000224	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.9e-05	0.000224	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.88e-05	0.000221	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.87e-05	0.000219	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	1.85e-05	0.000218	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.83e-05	0.000216	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.83e-05	0.000215	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.82e-05	0.000213	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.8e-05	0.000211	CbGpPWpGaD
Asenapine—ADRA2C—Hemostasis—TP53—amyotrophic lateral sclerosis	1.8e-05	0.000211	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.79e-05	0.000211	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—APOE—amyotrophic lateral sclerosis	1.79e-05	0.00021	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.77e-05	0.000208	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.76e-05	0.000207	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.75e-05	0.000206	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.73e-05	0.000204	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.73e-05	0.000203	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.72e-05	0.000203	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.72e-05	0.000203	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.72e-05	0.000202	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.72e-05	0.000202	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.72e-05	0.000202	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.71e-05	0.000201	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.7e-05	0.000199	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.69e-05	0.000198	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.67e-05	0.000197	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.66e-05	0.000195	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.65e-05	0.000194	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.65e-05	0.000194	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.65e-05	0.000194	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.65e-05	0.000194	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.63e-05	0.000192	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.62e-05	0.000191	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.62e-05	0.00019	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.61e-05	0.00019	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.6e-05	0.000189	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.6e-05	0.000188	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.59e-05	0.000187	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.58e-05	0.000186	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.57e-05	0.000185	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.57e-05	0.000184	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.54e-05	0.000181	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.54e-05	0.000181	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	1.52e-05	0.000179	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.49e-05	0.000176	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.48e-05	0.000174	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.47e-05	0.000173	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.47e-05	0.000173	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.46e-05	0.000172	CbGpPWpGaD
Asenapine—ADRA2A—Hemostasis—TP53—amyotrophic lateral sclerosis	1.46e-05	0.000172	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.46e-05	0.000171	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—APOE—amyotrophic lateral sclerosis	1.45e-05	0.000171	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.43e-05	0.000168	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.43e-05	0.000168	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.4e-05	0.000165	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.36e-05	0.000159	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.33e-05	0.000157	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.33e-05	0.000157	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.33e-05	0.000156	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.33e-05	0.000156	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.32e-05	0.000156	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.32e-05	0.000155	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.32e-05	0.000155	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.31e-05	0.000154	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.3e-05	0.000153	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.3e-05	0.000153	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.29e-05	0.000152	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.28e-05	0.00015	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.27e-05	0.000149	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.27e-05	0.000149	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.25e-05	0.000147	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.25e-05	0.000147	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.25e-05	0.000147	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.24e-05	0.000146	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.24e-05	0.000146	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.23e-05	0.000145	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.23e-05	0.000145	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.22e-05	0.000144	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.22e-05	0.000143	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.21e-05	0.000143	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.21e-05	0.000142	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.2e-05	0.000141	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.15e-05	0.000135	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.14e-05	0.000135	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.14e-05	0.000134	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.13e-05	0.000132	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.13e-05	0.000132	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.12e-05	0.000132	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.12e-05	0.000132	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.12e-05	0.000131	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.11e-05	0.00013	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.1e-05	0.00013	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.1e-05	0.000129	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.09e-05	0.000129	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.08e-05	0.000127	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.08e-05	0.000127	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.08e-05	0.000127	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.06e-05	0.000125	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.06e-05	0.000125	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.03e-05	0.000121	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.03e-05	0.000121	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.02e-05	0.00012	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1e-05	0.000118	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1e-05	0.000118	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.94e-06	0.000117	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	9.82e-06	0.000115	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	9.77e-06	0.000115	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.73e-06	0.000114	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	9.7e-06	0.000114	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.69e-06	0.000114	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	9.61e-06	0.000113	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.56e-06	0.000112	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	9.5e-06	0.000112	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	9.49e-06	0.000112	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	9.45e-06	0.000111	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	9.28e-06	0.000109	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	9.23e-06	0.000109	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.98e-06	0.000106	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.71e-06	0.000102	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.63e-06	0.000101	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.62e-06	0.000101	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.52e-06	0.0001	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.5e-06	0.0001	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.49e-06	9.99e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.48e-06	9.97e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.46e-06	9.95e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.44e-06	9.92e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.33e-06	9.8e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.3e-06	9.76e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.29e-06	9.74e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.26e-06	9.72e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.17e-06	9.61e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.14e-06	9.58e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.13e-06	9.56e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.06e-06	9.48e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.01e-06	9.42e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	8.01e-06	9.42e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8e-06	9.4e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.85e-06	9.23e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.76e-06	9.13e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.72e-06	9.07e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.51e-06	8.83e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.32e-06	8.61e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.31e-06	8.6e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.29e-06	8.57e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.22e-06	8.49e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.2e-06	8.46e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.18e-06	8.44e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.05e-06	8.29e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.58e-06	7.74e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.55e-06	7.7e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.52e-06	7.67e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.48e-06	7.62e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.44e-06	7.57e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.29e-06	7.4e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.26e-06	7.36e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	6.18e-06	7.27e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.09e-06	7.16e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.53e-06	6.5e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.49e-06	6.45e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.44e-06	6.39e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.43e-06	6.38e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.32e-06	6.26e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.95e-06	5.82e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.23e-06	4.98e-05	CbGpPWpGaD
